Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Oral Oncology|March 31, 2018
Overexpression of PIK3CA in head and neck squamous cell carcinoma is associated with poor outcome and activation of the YAP pathwayRamón García-Escudero, Carmen Segrelles, Marta Dueñas, et al.
European Journal of Immunology|February 4, 2020
Syncytin-1/HERV-W envelope is an early activation marker of leukocytes and is upregulated in multiple sclerosis patientsMarta Garcia-Montojo, Eulalia Rodriguez-Martin, Priscila Ramos-Mozo, et al.
Plos One|March 6, 2014
Human endogenous retrovirus HERV-Fc1 association with multiple sclerosis susceptibility: a meta-analysisBelén de la Hera, Jezabel Varadé, Marta García-Montojo, et al.
Antibiotics (Basel, Switzerland)|March 27, 2026
Trends, Seasonality, and the Impact of COVID-19 on Clinical Staphylococcus aureus and MRSA Isolates in Western Mexico (2016-2025): A Time-Series Analysis at a University Referral HospitalJaime Briseno-Ramírez, Pedro Martínez-Ayala, Adolfo Gómez-Quiroz, et al.
Scientific Reports|November 26, 2022
Endocannabinoid levels in peripheral blood mononuclear cells of multiple sclerosis patients treated with dimethyl fumarateAlicia Sánchez-Sanz, María Posada-Ayala, Julia Sabín-Muñoz, et al.
Plos One|May 10, 2013
Candidate gene study of TRAIL and TRAIL receptors: association with response to interferon beta therapy in multiple sclerosis patientsCarlos López-Gómez, Almudena Pino-Ángeles, Teresa Órpez-Zafra, et al.
Sensors (Basel, Switzerland)|December 10, 2021
COLAEVA: Visual Analytics and Data Mining Web-Based Tool for Virtual Coaching of Older Adult PopulationsJon Kerexeta Sarriegi, Andoni Beristain Iraola, Roberto Álvarez Sánchez, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 11, 2020
Serum antibodies to phosphatidylcholine in MSMaria Cruz Sádaba, Veit Rothhammer, Úrsula Muñoz, et al.
Plos One|August 5, 2011
TRAIL/TRAIL receptor system and susceptibility to multiple sclerosisCarlos López-Gómez, Oscar Fernández, Juan Antonio García-León, et al.
Frontiers in Immunology|October 16, 2023
Teriflunomide and Epstein-Barr virus in a Spanish multiple sclerosis cohort: in vivo antiviral activity and clinical responseMaría Inmaculada Domínguez-Mozo, Inés González-Suárez, Luisa María Villar, et al.
Pageof 6